Medical Rehabilitation after Coronavirus Disease (Covid-19)/ Re_Co

Organizational Data

DRKS-ID:
DRKS00023642
Recruitment Status:
Recruiting complete, study complete
Date of registration in DRKS:
2020-12-01
Last update in DRKS:
2024-01-08
Registration type:
Prospective

Acronym/abbreviation of the study

Re_Co

URL of the study

No Entry

Brief summary in lay language

Due to the novelty of Covid-19 disease, there have been few studies on rehabilitation measures for this patient group to date. The question arises which contents are used during the rehabilitation of Covid-19 patients and which long-term consequences of the disease can be observed in the rehabilitants. The fact that rehabilitation has positive effects in the case of a pneumological disease has already been proven in COPD and asthma rehabilitants. The aim of this study is to describe the long-term consequences of the rehabilitants after Covid-19 disease and to subsequently formulate recommendations for rehabilitation.

Brief summary in scientific language

Due to the novelty of Covid-19 disease, little is known about the necessary contents and structures of subsequent rehabilitation. Due to suspected long-term consequences of Covid-19 disease, scientific studies on the subject of rehabilitation with Covid-19 are being called for. After intensive care and / or respiration, patients need to learn in rehabilitation how to cope with the psychological, cognitive and physical consequences before returning home. The aim of this study is to derive recommendations for tailored rehabilitation concepts for patients with varying degrees of participation restrictions and psychological stress after Covid-19 disease and to explore suitable aftercare strategies. To be able to classify the findings, the rehabilitants will be compared to a group of COPD and asthma patients. In a prospective, explorative, multi-centre observational study, the study participants are interviewed at four points in time (start of rehabilitation, end of rehabilitation, 6 and 12 month follow-up). In four rehab facilities, rehabilitants are consecutively included in the study.

Health condition or problem studied

Free text:
U08.9 U09.9! U10.9
ICD10:
J45 - Asthma
ICD10:
J44 - Other chronic obstructive pulmonary disease
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
The rehabilitants receive pneumological rehabilitation and rehabilitation aftercare.

Endpoints

Primary outcome:
Participation (Index to Measure Impairment of Participation, IMET) at the start of rehabilitation and after 6 and 12 months; Quality of Life (VR12) at the start of rehabilitation, after rehabilitation and after 6 and 12 months
Secondary outcome:
At all four measurement points (start of rehab, after rehab and after 6 and 12 months) the following outcomes are assessed Depressiveness, anxiety, stress (DASS); stress-related psychomental limitations and disorders (GAD-7; PHQ-9; ITQ part 1); corona-associated life events (single items); effects of chronic obstructive pulmonary disease (CAT); fatigue (EORTC-FA 12); general health (individual items); performance in different areas of life (QGmR); assessment of work ability (Work Ability Score WAS); subjective prognosis of employment (PES scale) Occupational changes (through individual questions from the QGmR) are recorded after 6 and 12 months

Study Design

Purpose:
Other
Retrospective/prospective:
Prospective
Study type:
Non-interventional
Longitudinal/cross-sectional:
Longitudinal study
Study type non-interventional:
No Entry

Recruitment

Recruitment Status:
Recruiting complete, study complete
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Multicenter study
Recruitment location(s):
  • Medical center MEDIAN Klinik Heiligendamm Heiligendamm
  • Medical center Ostseeklinik Schönberg-Holm Schönberg-Holm
  • Medical center Reha-Zentrum Schömberg Schömberg
  • Medical center MEDIAN Klinik Flechtingen Flechtingen

Recruitment period and number of participants

Planned study start date:
2021-02-01
Actual study start date:
2021-02-05
Planned study completion date:
2023-11-30
Actual Study Completion Date:
2023-11-30
Target Sample Size:
580
Final Sample Size:
542

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
65 Years
Additional Inclusion Criteria:
The study will include insured persons who are eligible for work after different severity of covid-19 disease (ICD: U07.1!). They no longer require isolation and are between 18 and 65 years old. Study participants in the comparison group have a diagnosed obstructive respiratory disease such as bronchial asthma or COPD with a comparable age range and a comparable distribution in terms of gender and ability to work.

Exclusion Criteria

Rehabilitants with insufficient knowledge of German are excluded from the study. The costs of rehabilitation may not be borne by the employers' liability insurance association. In addition, discontinuation of the rehabilitation measure and lack of consent to participate in the study are exclusion criteria.

Addresses

Primary Sponsor

Address:
Institut für Sozialmedizin und Epidemiologie, Universität zu Lübeck
Ratzeburger Allee 160
23538 Lübeck
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Institut für Sozialmedizin und Epidemiologie, Universität zu Lübeck
Prof. Dr. Ruth Deck
Ratzeburger Allee 160
23538 Lübeck
Germany
Telephone:
0451 500 51211
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Contact for Public Queries

Address:
Institut für Sozialmedizin und Epidemiologie, Universität zu Lübeck
Prof. Dr. Ruth Deck
Ratzeburger Allee 160
23538 Lübeck
Germany
Telephone:
0451 500 51211
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Principal Investigator

Address:
Institut für Sozialmedizin und Epidemiologie, Universität zu Lübeck
Prof. Dr. Ruth Deck
Ratzeburger Allee 160
23538 Lübeck
Germany
Telephone:
0451 500 51211
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Sources of Monetary or Material Support

Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)

Address:
Deutsche Rentenversicherung Bund
Ruhrstraße 2
10709 Berlin
Germany
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Ethik-Kommission der Med. Fakultät der Universität zu Lübeck
Ratzeburger Allee 160
23538 Lübeck
Germany
Telephone:
+49-451-5004639
Fax:
+49-451-5003026
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2020-09-30
Ethics committee number:
20-391
Vote of the Ethics Committee:
Approved
Date of the vote:
2020-11-05

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
Studieprotokoll ReCo
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
Mercedes Rutsch , Jördis Frommhold , Heike Buhr-Schinner , Thomas Gross , Per Otto Schüller , Ruth Deck (2023): Pneumologische Rehabilitation bei Long Covid – Gesundheitliche Veränderungen am Ende der stationären Rehabilitationsmaßnahme. Die Rehabilitation.
Date of first publication of study results:
2023-01-17
DRKS entry published for the first time with results:
2023-04-27

Basic reporting